Biogen Says Diranersen Showed Clinical Benefits Across Studied Doses
Biogen said the 60 mg dose group showed compelling efficacy and a favorable benefit-risk profile.
Biogen said the 60 mg dose group showed compelling efficacy and a favorable benefit-risk profile.